 - Patients not in remission must have CD45-expressing leukemic blasts or myelodysplastic cells; patients in remission do not require phenotyping and may have leukemia previously documented to be CD45 negative because in remission patients, virtually all antibody binding is to non-malignant cells which make up 95 of nucleated cells in the marrow 